Guilford regulatory update

GLFD received four U.S. Patents. Nos. 5,859,031 and 5,874,449 cover small molecule FKBP-neuroimmunophilin ligands to treat and prevent neurodegenerative disorders such as Parkinson's disease and Alzhe...